Bosentan 68180-0340-13

Package NDC

68180-0340-13

Manufacturer: Lupin Pharmaceuticals, Inc.
Dosage Form: Tablet, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: August 18, 2025
Listing Expires: December 31, 2026
Application: ANDA213154

Need to source Bosentan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bosentan	32 mg/1

Drug Class

Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A Inducers [MoA]Endothelin Receptor Antagonist [EPC]

Selected Package

68180-0340-13Selected

4 BLISTER PACK in 1 CARTON (68180-340-13) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK